Clinical outcomes of myeloid/lymphoid neoplasms with fibroblast growth factor receptor-1 (FGFR1) rearrangement

References

• Macdonald D, Aguiar RC, Mason PJ, et al. A new myeloproliferative disorder associated with chromosomal translocations involving 8p11: a review. Leukemia. 1995;9(10):1628–1630. PubMed PMID: 7564500; eng.
   PubMed Web of Science ®Google Scholar
• Vega F, Medeiros LJ, Bueso-Ramos CE, et al. Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1. Am J Clin Pathol. 2015;144(3):377–392. doi:10.1309/ajcpmorr5z2ikcem. PubMed PMID: 26276769; eng.
   PubMed Web of Science ®Google Scholar
• Jackson CC, Medeiros LJ, Miranda RN. 8p11 myeloproliferative syndrome: a review. Human Pathol. 2010;41(4):461–476. doi:10.1016/j.humpath.2009.11.003. PubMed PMID: 20226962; eng.
   PubMed Web of Science ®Google Scholar
• Khodadoust MS, Luo B, Medeiros BC, et al. Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia. Leukemia. 2016;30(4):947–950. doi:10.1038/leu.2015.136. PubMed PMID: 26055304; eng.
   PubMed Web of Science ®Google Scholar
• Duckworth CB, Zhang L, Li S. Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: report of a unique case. Int J Clin Exp Pathol. 2014;7(2):801–807. PubMed PMID: 24551307; PubMed Central PMCID: PMCPmc3925931. eng.
   PubMed Web of Science ®Google Scholar
• Morishige S, Oku E, Takata Y, et al. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation. Acta Haematol. 2013;129(2):83–89. doi:10.1159/000341289. PubMed PMID: 23171834; eng.
   PubMed Web of Science ®Google Scholar
• Haslam K, Langabeer SE, Kelly J, et al. Allogeneic hematopoietic stem cell transplantation for a BCR-FGFR1 myeloproliferative neoplasm presenting as acute lymphoblastic leukemia. Case Rep Hematol. 2012;2012:620967. doi:10.1155/2012/620967. PubMed PMID: 23082258; PubMed Central PMCID: PMCPmc3467796. eng.
   PubMedGoogle Scholar
• Shaaban H, Dabu J, Al-Rabi K, et al. A rare case report of 8p11 myeloid and lymphoid neoplasm with FGFR1 abnormality in a young adult. Ann Hematol. 2013;92(2):285–286. doi:10.1007/s00277-012-1562-7. PubMed PMID: 22941307; eng.
   PubMed Web of Science ®Google Scholar
• Li F, Zhai YP, Tang YM, et al. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome. Genes Chromosom Cancer. 2012;51(9):890–897. doi:10.1002/gcc.21973. PubMed PMID: 22619110; eng.
   PubMed Web of Science ®Google Scholar
• Dolan M, Cioc A, Cross NC, et al. Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion. Pediatr Blood Cancer. 2012;59(1):194–196. doi:10.1002/pbc.23404. PubMed PMID: 22106025; eng.
   PubMed Web of Science ®Google Scholar
• Suzan F, Guasch G, Terre C, et al. Long-term complete haematological and molecular remission after allogeneic bone marrow transplantation in a patient with a stem cell myeloproliferative disorder associated with t(8;13)(p12;q12). Br J Haematol. 2003;121(2):312–314. PubMed PMID: 12694254; eng. doi: 10.1046/j.1365-2141.2003.04269.x
   PubMed Web of Science ®Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458. doi:10.1038/bmt.2012.244. PubMed PMID: 23208313; PubMed Central PMCID: PMCPmc3590441. eng.
   PubMed Web of Science ®Google Scholar
• Sarthy JF, Reddivalla N, Radhi M, et al. Pediatric 8p11 eosinophilic myeloproliferative syndrome (EMS): a case report and review of the literature. Pediatr Blood Cancer. 2016. doi:10.1002/pbc.26310. PubMed PMID: 27808462; eng.
   PubMed Web of Science ®Google Scholar
• Qin YW, Yang YN, Bai P, et al. Chronic myelogenous leukemia-like hematological malignancy with t(8;22) in a 26-year-old pregnant woman: a case report. Oncol Lett. 2016;11(6):4131–4133. doi:10.3892/ol.2016.4505. PubMed PMID: 27313753; PubMed Central PMCID: PMCPmc4888210. eng.
   PubMed Web of Science ®Google Scholar
• Malli T, Buxhofer-Ausch V, Rammer M, et al. Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome. Genes Chromosom Cancer. 2016;55(1):60–68. doi:10.1002/gcc.22311. PubMed PMID: 26391436; eng.
   PubMed Web of Science ®Google Scholar
• Kumar KR, Chen W, Koduru PR, et al. Myeloid and lymphoid neoplasm with abnormalities of FGFR1 presenting with trilineage blasts and RUNX1 rearrangement: a case report and review of literature. Am J Clin Pathol. 2015;143(5):738–748. doi:10.1309/ajcpud6w1jlqqmna. PubMed PMID: 25873510; eng.
   PubMed Web of Science ®Google Scholar
• Chao H, Zhou M, Zhang R. A case with ZNF198-FGFR1 gene rearrangement presenting as acute eosinophil myeloid leukemia. Chin Med J. 2015;128(1):131–132. doi:10.4103/0366-6999.147863. PubMed PMID: 25563327; PubMed Central PMCID: PMCPmc4837809. eng.
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Ito Y, Wakimoto N, et al. A novel fusion of SQSTM1 and FGFR1 in a patient with acute myelomonocytic leukemia with t(5;8)(q35;p11) translocation. Blood Cancer J. 2014;4:e265. doi:10.1038/bcj.2014.86. PubMed PMID: 25501022; PubMed Central PMCID: PMCPmc4315892. eng.
   PubMed Web of Science ®Google Scholar
• Patel RA, Sheehan AM, Finch CJ, et al. Fine-needle aspiration cytology of T-lymphoblastic lymphoma associated FGFR1 rearrangement myeloproliferative neoplasm. Diagn Cytopathol. 2014;42(1):45–48. doi:10.1002/dc.23030. PubMed PMID: 23904402; PubMed Central PMCID: PMCPmc4100463. eng.
   PubMed Web of Science ®Google Scholar
• Buijs A, van Wijnen M, van den Blink D, et al. A ZMYM2-FGFR1 8p11 myeloproliferative neoplasm with a novel nonsense RUNX1 mutation and tumor lysis upon imatinib treatment. Cancer Genet. 2013;206(4):140–144. doi:10.1016/j.cancergen.2013.04.001. PubMed PMID: 23751892; eng.
   PubMed Web of Science ®Google Scholar
• Lee H, Kim M, Lim J, et al. Acute myeloid leukemia associated with FGFR1 abnormalities. Int J Hemat. 2013;97(6):808–812. doi:10.1007/s12185-013-1337-5. PubMed PMID: 23609419; eng.
   PubMed Web of Science ®Google Scholar
• Trimaldi J, Carballido EM, Bowers JW, et al. B-lymphoblastic leukemia/lymphoma associated with t(8;13)(p11;q12)/ ZMYM2 (ZNF198)-FGFR1: rare case and review of the literature. Acta Haematol. 2013;130(3):127–134. doi:10.1159/000347030. PubMed PMID: 23594707; eng.
   PubMed Web of Science ®Google Scholar
• Matikas A, Tzannou I, Oikonomopoulou D, et al. A case of acute myelogenous leukaemia characterised by the BCR-FGFR1 translocation. BMJ Case Rep. 2013;2013. doi:10.1136/bcr-2013-008834. PubMed PMID: 23519513; PubMed Central PMCID: PMCPmc3618816. eng.
   Google Scholar
• Yamamoto S, Ebihara Y, Mochizuki S, et al. Quantitative polymerase chain reaction detection of CEP110-FGFR1 fusion gene in a patient with 8p11 myeloproliferative syndrome. Leuk Lymphoma. 2013;54(9):2068–2069. doi:10.3109/10428194.2013.767455. PubMed PMID: 23327291; eng.
   PubMed Web of Science ®Google Scholar
• Gervais C, Dano L, Perrusson N, et al. A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm. Leukemia. 2013;27(5):1186–1188. doi:10.1038/leu.2012.286. PubMed PMID: 23041776; eng.
   PubMed Web of Science ®Google Scholar
• Mayeur-Rousse C, Sorel N, Voldoire M, et al. Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene. Leuk Res. 2012;36(3):377–381. doi:10.1016/j.leukres.2011.10.009. PubMed PMID: 22030335; eng.
   PubMed Web of Science ®Google Scholar
• Kim SY, Oh B, She CJ, et al. 8p11 Myeloproliferative syndrome with BCR-FGFR1 rearrangement presenting with T-lymphoblastic lymphoma and bone marrow stromal cell proliferation: a case report and review of the literature. Leuk Res. 2011;35(5):e30–e34. doi:10.1016/j.leukres.2010.12.014. PubMed PMID: 21239058; eng.
   PubMed Web of Science ®Google Scholar
• Zhou L, Fu W, Yuan Z, et al. Complete molecular remission after interferon alpha treatment in a case of 8p11 myeloproliferative syndrome. Leuk Res. 2010;34(11):e306–e307. doi:10.1016/j.leukres.2010.06.027. PubMed PMID: 20650528; eng.
   PubMed Web of Science ®Google Scholar
• Baldazzi C, Iacobucci I, Luatti S, et al. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene. Leuk Res. 2010;34(10):e282–e285. doi:10.1016/j.leukres.2010.05.009. PubMed PMID: 20594995; eng.
   PubMed Web of Science ®Google Scholar
• Post GR, Holloman D, Christiansen L, et al. Translocation t(3;8;9)(p25;p21;q34) in a patient with features of 8p11 myeloproliferative syndrome: a unique case and review of the literature. Leuk Res. 2010;34(11):1543–1544. doi:10.1016/j.leukres.2010.05.017. PubMed PMID: 20541805; eng.
   PubMed Web of Science ®Google Scholar
• Zhang WW, Habeebu S, Sheehan AM, et al. Molecular monitoring of 8p11 myeloproliferative syndrome in an infant. J Pediatr Hematol Oncol. 2009;31(11):879–883. doi:10.1097/MPH.0b013e3181b83fd0. PubMed PMID: 19829149; eng.
   PubMed Web of Science ®Google Scholar
• Soler G, Nusbaum S, Varet B, et al. LRRFIP1, a new FGFR1 partner gene associated with 8p11 myeloproliferative syndrome. Leukemia. 2009;23(7):1359–1361. doi:10.1038/leu.2009.79. PubMed PMID: 19369959; eng.
   PubMed Web of Science ®Google Scholar
• Park TS, Song J, Kim JS, et al. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality. Cancer Genet Cytogenet. 2008;181(2):93–99. doi:10.1016/j.cancergencyto.2007.11.011. PubMed PMID: 18295660; eng.
   PubMedGoogle Scholar
• Etienne A, Gelsi-Boyer V, Carbuccia N, et al. Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder. Cancer Genet Cytogenet. 2007;173(2):154–158. doi:10.1016/j.cancergencyto.2006.10.004. PubMed PMID: 17321332; eng.
   PubMedGoogle Scholar
• Yamamoto K, Kawano H, Nishikawa S, et al. A biphenotypic transformation of 8p11 myeloproliferative syndrome with CEP1/FGFR1 fusion gene. Eur J Haematol. 2006;77(4):349–354. doi:10.1111/j.1600-0609.2006.00723.x. PubMed PMID: 16879608; eng.
   PubMed Web of Science ®Google Scholar
• Wong WS, Cheng KC, Lau KM, et al. Clonal evolution of 8p11 stem cell syndrome in a 14-year-old Chinese boy: a review of literature of t(8;13) associated myeloproliferative diseases. Leuk Res. 2007;31(2):235–238. doi:10.1016/j.leukres.2006.04.015. PubMed PMID: 16777224; eng.
   PubMed Web of Science ®Google Scholar
• Mozziconacci MJ, Carbuccia N, Prebet T, et al. Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110-FGFR1 fusion: report of a new case and review of the literature. Leuk Res. 2008;32(8):1304–1308. doi:10.1016/j.leukres.2007.11.012. PubMed PMID: 18096225; eng.
   PubMed Web of Science ®Google Scholar
• Hidalgo-Curtis C, Chase A, Drachenberg M, et al. The t(1;9)(p34;q34) and t(8;12)(p11;q15) fuse pre-mRNA processing proteins SFPQ (PSF) and CPSF6 to ABL and FGFR1. Genes Chromosom Cancer. 2008;47(5):379–385. doi:10.1002/gcc.20541. PubMed PMID: 18205209; eng.
   PubMed Web of Science ®Google Scholar
• Belloni E, Trubia M, Gasparini P, et al. 8p11 myeloproliferative syndrome with a novel t(7;8) translocation leading to fusion of the FGFR1 and TIF1 genes. Genes Chromosom Cancer. 2005;42(3):320–325. doi:10.1002/gcc.20144. PubMed PMID: 15609342; eng.
   PubMed Web of Science ®Google Scholar
• Vizmanos JL, Hernandez R, Vidal MJ, et al. Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: two further cases. Hematol J. 2004;5(6):534–537. doi:10.1038/sj.thj.6200561. PubMed PMID: 15570299; eng.
   PubMedGoogle Scholar
• Mugneret F, Chaffanet M, Maynadie M, et al. The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene. Br J Haematol. 2000;111(2):647–649. PubMed PMID: 11122115; eng. doi: 10.1046/j.1365-2141.2000.02355.x
   PubMed Web of Science ®Google Scholar
• Guasch G, Mack GJ, Popovici C, et al. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). Blood. 2000;95(5):1788–1796. PubMed PMID: 10688839; eng.
   PubMed Web of Science ®Google Scholar
• Popovici C, Zhang B, Gregoire MJ, et al. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor receptor 1. Blood. 1999;93(4):1381–1389. PubMed PMID: 9949182; eng.
   PubMed Web of Science ®Google Scholar
• Cowell JK, Qin H, Chang CS, et al. A model of BCR-FGFR1 driven human AML in immunocompromised mice. Br J Haematol. 2016;175(3):542–545. doi:10.1111/bjh.13877. PubMed PMID: 27785808; eng.
   PubMed Web of Science ®Google Scholar
• Wakim JJ, Tirado CA, Chen W, et al. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature. Leuk Res. 2011;35(9):e151–e153. doi:10.1016/j.leukres.2011.05.013. PubMed PMID: 21628071; eng.
   PubMed Web of Science ®Google Scholar